JPRN-UMIN000002334已完成未知
Effect of dopamine receptor agonists on treatment-resistant depression - DATRD
Department of Psychiatry, Hokkaido University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2009年8月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
Pramipexole was effective for treatment-resistant depression in our small open study.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) allergy for dopamine agonists, 2) allergy for antidepressants, 3) severe psychotic symptoms, 4) consciousness disturbance, 5) severe hypotension, 6) severe physical disease (heart, lung, liver, kidney, bone marrow, endocrine), 7)peripheral vascular disease, 8) active ulcer, 9) pregnancy, breast-feeding, 10) subjects, whom investigators consider inappropriate
研究者
相似试验
已完成
不适用
Pramipexole and Emotional ProcessingEmotionsMotivationRewardDopamineNCT03681509University of Oxford43
已完成
2 期
Lexapro and Pramipexole and to Treat Major DepressionMajor DepressionNCT00086307National Institute of Mental Health (NIMH)39
已完成
4 期
Effectiveness of Pramipexole for Treatment-Resistant DepressionDepressionNCT00231959Massachusetts General Hospital65
已完成
2 期
Clinical Trial of Pramipexole in Bipolar DepressionBipolar DisorderNCT00025792National Institute of Mental Health (NIMH)200
Unknown
4 期
A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.Bipolar DisorderMajor Depressive DisorderNCT00335205Sheba Medical Center60